Ragon Institute

News

Filter By:

Clear All

A boost for HIV vaccine research

May 20, 2024 Features

HIV has proven a hard target for vaccine design. The most promising approach, germline-targeting (GT), proposes a series of immunizations: a first shot to activate inexperienced B cells—antibody-producing white blood cells—followed by a sequence of immunogens that are more and more like the HIV Envelope (Env) protein. The ultimate goal of GT immunization is to […]

Ragon Faculty Present at 2024 ATI Consensus Workshop

May 10, 2024 Features

The second installment of the event aimed to create new guidelines for ATIs, including pediatric ATIs In a significant follow-up to the groundbreaking 2018 Consensus Symposium on HIV Analytical Treatment Interruption (ATI) hosted at the Ragon Institute, several faculty members helped organize and participated in the 2024 ATI Consensus Workshop held this week in Nairobi, […]

Ragon Faculty Study Identifies Novel Immunization Strategy for Broad Influenza Protection

Apr 29, 2024 Features

Researchers at the Ragon Institute have developed a novel immunization strategy that shows promise for protecting against both group 1 and group 2 influenza A viruses. The strategy, detailed in their recent study, relies on eliciting a single amino acid change in antibodies to generate broadly neutralizing antibodies (bnAbs). Ragon faculty members Daniel Lingwood, PhD, […]

Ragon Study Finds Key Mechanism of Immune Evasion by SARS-CoV-2

Apr 23, 2024 Features

A collaborative research study led by Ragon Institute faculty member and Early Independence fellow Wilfredo F. Garcia-Beltran, MD, PhD, and Ragon Biosafety Level 3 Core co-director Julie Boucau, PhD, has uncovered a critical mechanism by which SARS-CoV-2 evades one of the body’s key immune responses, providing new insights that could lead to novel treatments. Their […]

Ragon faculty sheds light on intricate functions of Resident Tissue Macrophages (RTM’s) which extend beyond immune defense

Apr 15, 2024 Features

The lab of the Ragon Institute faculty member Hernandez Moura Silva, PhD, recently published a review in Science Immunology regarding resident tissue macrophages (RTMs), shedding light on their multifaceted roles in organ health.  RTMs, integral components found abundantly across various organs, have traditionally been recognized for their immune defense functions. However, this review highlights their contributions extend […]

Brandon DeKosky one of five MIT faculty members awarded by Cancer Grand Challenges

Mar 29, 2024 Features

The team will receive $25 million to work towards treatments for cancer Ragon core member and MIT associate professor of chemical engineering Brandon DeKosky, PhD, was one of five MIT faculty members recently awarded $25 million to take on Cancer Grand Challenges. Cancer Grand Challenges announced five winning teams for 2024, which included DeKosky and […]

Ragon Institute Introduces Catherine Othieno Sempa Memorial Post Baccalaureate Scholars Program

Mar 13, 2024

A two-year opportunity in medical science research and career development for underrepresented students About the Program The Catherine Othieno Sempa* Memorial Post Baccalaureate Scholars Program engages talented college graduates from HBCUs and Puerto Rican universities in a comprehensive and immersive two-year program in immunology research. The program is designed to diversify the field of academic […]

Hernandez Moura Silva Awarded MLK Leadership Award from MIT

Mar 5, 2024 Features

Ragon faculty member Hernandez Moura Silva, PhD, was recently awarded the MIT 2024 Martin Luther King Jr. Leadership Award for faculty. MLK Leadership Awards are given annually to students, alumni, staff, groups, and faculty members who embody the spirit of Dr. King’s work. “Service to the community” is defined in the broadest sense and includes […]

PRESS RELEASE – Ragon faculty study finds combination of two drugs increases the vulnerability of HIV-1 reservoir cells to the immune system.

Feb 29, 2024 Features

Ragon faculty Mathias Lichterfeld, MD, PhD, and Xu Yu, MD, have co-authored a paper published in Cell which found evidence that a combination of two drugs increases the vulnerability of HIV-1 reservoir cells to the immune system — which shows promising results in targeting and reducing the HIV-1 reservoir in people living with HIV. Using […]

REITHERA SRL, THE RAGON INSTITUTE AND IAVI ANNOUNCE COLLABORATION TO ADVANCE HIGHLY NETWORKED T CELL HIV VACCINE CANDIDATE TOWARDS PHASE I CLINICAL EVALUATION

Feb 5, 2024 Features

Novel HIV vaccine candidate based on Gorilla adenoviral vector (GRAd-HIV) funded by The Bill & Melinda Gates Foundation to alleviate the disease burden and improve the lives of the millions who lack access to prevention options ReiThera Srl, the Ragon Institute of Mass General, MIT, and Harvard, and IAVI are pleased to announce a collaboration […]